These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 18045823)

  • 1. Th17 cells: a third subset of CD4+ T effector cells involved in organ-specific autoimmunity.
    Kurts C
    Nephrol Dial Transplant; 2008 Mar; 23(3):816-9. PubMed ID: 18045823
    [No Abstract]   [Full Text] [Related]  

  • 2. Subsets of CD4 T cells and B cell activation.
    Bottomly K
    Semin Immunol; 1989 Sep; 1(1):21-31. PubMed ID: 15630956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Th17 cells, a novel proinflammatory effector CD4 T cell population].
    Leung-Theung-Long S; Guerder S
    Med Sci (Paris); 2008 Nov; 24(11):972-6. PubMed ID: 19038101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Memory IL-22-producing CD4+ T cells specific for Candida albicans are present in humans.
    Liu Y; Yang B; Zhou M; Li L; Zhou H; Zhang J; Chen H; Wu C
    Eur J Immunol; 2009 Jun; 39(6):1472-9. PubMed ID: 19449309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T cells. Introduction.
    Shevach EM
    Semin Immunol; 2004 Apr; 16(2):69-71. PubMed ID: 15036229
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostaglandin E2 enhances Th17 responses via modulation of IL-17 and IFN-gamma production by memory CD4+ T cells.
    Napolitani G; Acosta-Rodriguez EV; Lanzavecchia A; Sallusto F
    Eur J Immunol; 2009 May; 39(5):1301-12. PubMed ID: 19384872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission.
    Abdulahad WH; Stegeman CA; Limburg PC; Kallenberg CG
    Arthritis Rheum; 2008 Jul; 58(7):2196-205. PubMed ID: 18576340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specifying helper T cell fates during immunity.
    Chang JT; Reiner SL
    J Pediatr Gastroenterol Nutr; 2008 Apr; 46 Suppl 1():E19-20. PubMed ID: 18354322
    [No Abstract]   [Full Text] [Related]  

  • 9. [Perspectives for the immunotherapy of condylomata].
    Bourgault Villada I
    Ann Dermatol Venereol; 2000; 127(10 Suppl):3S23-3S25. PubMed ID: 11116860
    [No Abstract]   [Full Text] [Related]  

  • 10. Phenotypic classification of human CD4+ T cell subsets and their differentiation.
    Okada R; Kondo T; Matsuki F; Takata H; Takiguchi M
    Int Immunol; 2008 Sep; 20(9):1189-99. PubMed ID: 18635582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta indirectly favors the development of human Th17 cells by inhibiting Th1 cells.
    Santarlasci V; Maggi L; Capone M; Frosali F; Querci V; De Palma R; Liotta F; Cosmi L; Maggi E; Romagnani S; Annunziato F
    Eur J Immunol; 2009 Jan; 39(1):207-15. PubMed ID: 19130583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection with a helminth parasite attenuates autoimmunity through TGF-beta-mediated suppression of Th17 and Th1 responses.
    Walsh KP; Brady MT; Finlay CM; Boon L; Mills KH
    J Immunol; 2009 Aug; 183(3):1577-86. PubMed ID: 19587018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-bet inhibits the in vivo differentiation of parasite-specific CD4+ Th17 cells in a T cell-intrinsic manner.
    Guo S; Cobb D; Smeltz RB
    J Immunol; 2009 May; 182(10):6179-86. PubMed ID: 19414771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Airway infiltration of CD4+ CCR6+ Th17 type cells associated with chronic cigarette smoke induced airspace enlargement.
    Harrison OJ; Foley J; Bolognese BJ; Long E; Podolin PL; Walsh PT
    Immunol Lett; 2008 Nov; 121(1):13-21. PubMed ID: 18706444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple roles for CD4+ T cells in anti-tumor immune responses.
    Kennedy R; Celis E
    Immunol Rev; 2008 Apr; 222():129-44. PubMed ID: 18363998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired CD4 and CD8 effector function and decreased memory T cell populations in ICOS-deficient patients.
    Takahashi N; Matsumoto K; Saito H; Nanki T; Miyasaka N; Kobata T; Azuma M; Lee SK; Mizutani S; Morio T
    J Immunol; 2009 May; 182(9):5515-27. PubMed ID: 19380800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral CD4+CD8+cells are the activated T cells expressed granzyme B (GrB), Foxp3, interleukin 17 (IL-17), at higher levels in Th1/Th2 cytokines.
    Xie D; Hai B; Xie X; Liu L; Ayello J; Ma X; Zhang J
    Cell Immunol; 2009; 259(2):157-64. PubMed ID: 19616200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-9: basic biology, signaling pathways in CD4+ T cells and implications for autoimmunity.
    Li H; Rostami A
    J Neuroimmune Pharmacol; 2010 Jun; 5(2):198-209. PubMed ID: 20020328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypical characterization of human Th17 cells unambiguously identified by surface IL-17A expression.
    Brucklacher-Waldert V; Steinbach K; Lioznov M; Kolster M; Hölscher C; Tolosa E
    J Immunol; 2009 Nov; 183(9):5494-501. PubMed ID: 19843935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the development and effector functions of TH17 cells.
    Ghilardi N; Ouyang W
    Semin Immunol; 2007 Dec; 19(6):383-93. PubMed ID: 18083530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.